Logo image of MDLZ

MONDELEZ INTERNATIONAL INC-A (MDLZ) Stock Fundamental Analysis

NASDAQ:MDLZ - Nasdaq - US6092071058 - Common Stock - Currency: USD

66.39  +0.9 (+1.37%)

Fundamental Rating

4

MDLZ gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 90 industry peers in the Food Products industry. While MDLZ has a great profitability rating, there are quite some concerns on its financial health. MDLZ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

MDLZ had positive earnings in the past year.
In the past year MDLZ had a positive cash flow from operations.
In the past 5 years MDLZ has always been profitable.
Each year in the past 5 years MDLZ had a positive operating cash flow.
MDLZ Yearly Net Income VS EBIT VS OCF VS FCFMDLZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

The Return On Assets of MDLZ (5.22%) is better than 67.78% of its industry peers.
Looking at the Return On Equity, with a value of 13.97%, MDLZ is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
The Return On Invested Capital of MDLZ (6.95%) is better than 71.11% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MDLZ is in line with the industry average of 8.67%.
Industry RankSector Rank
ROA 5.22%
ROE 13.97%
ROIC 6.95%
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
MDLZ Yearly ROA, ROE, ROICMDLZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 9.88%, MDLZ belongs to the best of the industry, outperforming 85.56% of the companies in the same industry.
MDLZ's Profit Margin has declined in the last couple of years.
The Operating Margin of MDLZ (12.62%) is better than 81.11% of its industry peers.
MDLZ's Operating Margin has improved in the last couple of years.
MDLZ has a Gross Margin of 32.74%. This is in the better half of the industry: MDLZ outperforms 74.44% of its industry peers.
In the last couple of years the Gross Margin of MDLZ has remained more or less at the same level.
Industry RankSector Rank
OM 12.62%
PM (TTM) 9.88%
GM 32.74%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
MDLZ Yearly Profit, Operating, Gross MarginsMDLZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

MDLZ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MDLZ has been reduced compared to 1 year ago.
MDLZ has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MDLZ has an improved debt to assets ratio.
MDLZ Yearly Shares OutstandingMDLZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
MDLZ Yearly Total Debt VS Total AssetsMDLZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

MDLZ has an Altman-Z score of 2.52. This is not the best score and indicates that MDLZ is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of MDLZ (2.52) is comparable to the rest of the industry.
The Debt to FCF ratio of MDLZ is 5.90, which is a neutral value as it means it would take MDLZ, 5.90 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.90, MDLZ is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
A Debt/Equity ratio of 0.69 indicates that MDLZ is somewhat dependend on debt financing.
MDLZ has a Debt to Equity ratio of 0.69. This is in the lower half of the industry: MDLZ underperforms 61.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 5.9
Altman-Z 2.52
ROIC/WACC0.87
WACC7.97%
MDLZ Yearly LT Debt VS Equity VS FCFMDLZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

MDLZ has a Current Ratio of 0.61. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
MDLZ has a worse Current ratio (0.61) than 86.67% of its industry peers.
MDLZ has a Quick Ratio of 0.61. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
MDLZ's Quick ratio of 0.40 is on the low side compared to the rest of the industry. MDLZ is outperformed by 78.89% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.4
MDLZ Yearly Current Assets VS Current LiabilitesMDLZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

3

3. Growth

3.1 Past

The earnings per share for MDLZ have decreased by -3.86% in the last year.
The Earnings Per Share has been growing slightly by 6.91% on average over the past years.
MDLZ shows a small growth in Revenue. In the last year, the Revenue has grown by 0.90%.
Measured over the past years, MDLZ shows a small growth in Revenue. The Revenue has been growing by 7.09% on average per year.
EPS 1Y (TTM)-3.86%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-22.11%
Revenue 1Y (TTM)0.9%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%0.25%

3.2 Future

The Earnings Per Share is expected to grow by 4.43% on average over the next years.
The Revenue is expected to grow by 3.62% on average over the next years.
EPS Next Y-10.75%
EPS Next 2Y-0.93%
EPS Next 3Y2.37%
EPS Next 5Y4.43%
Revenue Next Year4.78%
Revenue Next 2Y4.5%
Revenue Next 3Y4.26%
Revenue Next 5Y3.62%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MDLZ Yearly Revenue VS EstimatesMDLZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
MDLZ Yearly EPS VS EstimatesMDLZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

MDLZ is valuated rather expensively with a Price/Earnings ratio of 20.49.
MDLZ's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 25.91, MDLZ is valued a bit cheaper.
A Price/Forward Earnings ratio of 19.61 indicates a rather expensive valuation of MDLZ.
Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than the industry average as 64.44% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.85, MDLZ is valued at the same level.
Industry RankSector Rank
PE 20.49
Fwd PE 19.61
MDLZ Price Earnings VS Forward Price EarningsMDLZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDLZ.
The rest of the industry has a similar Price/Free Cash Flow ratio as MDLZ.
Industry RankSector Rank
P/FCF 25.95
EV/EBITDA 17.07
MDLZ Per share dataMDLZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The decent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.96
EPS Next 2Y-0.93%
EPS Next 3Y2.37%

6

5. Dividend

5.1 Amount

MDLZ has a Yearly Dividend Yield of 2.89%. Purely for dividend investing, there may be better candidates out there.
MDLZ's Dividend Yield is a higher than the industry average which is at 4.58.
MDLZ's Dividend Yield is a higher than the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 2.89%

5.2 History

The dividend of MDLZ is nicely growing with an annual growth rate of 10.52%!
MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.52%
Div Incr Years10
Div Non Decr Years10
MDLZ Yearly Dividends per shareMDLZ Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

66.48% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
MDLZ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP66.48%
EPS Next 2Y-0.93%
EPS Next 3Y2.37%
MDLZ Yearly Income VS Free CF VS DividendMDLZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
MDLZ Dividend Payout.MDLZ Dividend Payout, showing the Payout Ratio.MDLZ Dividend Payout.PayoutRetained Earnings

MONDELEZ INTERNATIONAL INC-A

NASDAQ:MDLZ (5/23/2025, 2:38:08 PM)

66.39

+0.9 (+1.37%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-28 2025-07-28/amc
Inst Owners85.54%
Inst Owner Change2.56%
Ins Owners0.14%
Ins Owner Change3.27%
Market Cap85.96B
Analysts75.56
Price Target73.07 (10.06%)
Short Float %1.64%
Short Ratio2.23
Dividend
Industry RankSector Rank
Dividend Yield 2.89%
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP66.48%
Div Incr Years10
Div Non Decr Years10
Ex-Date03-31 2025-03-31 (0.47)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.56%
Min EPS beat(2)-3.07%
Max EPS beat(2)10.18%
EPS beat(4)3
Avg EPS beat(4)7.09%
Min EPS beat(4)-3.07%
Max EPS beat(4)14.26%
EPS beat(8)7
Avg EPS beat(8)6.28%
EPS beat(12)11
Avg EPS beat(12)5.79%
EPS beat(16)12
Avg EPS beat(16)4.71%
Revenue beat(2)0
Avg Revenue beat(2)-2.21%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)-2.09%
Revenue beat(4)0
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)-0.99%
Revenue beat(8)2
Avg Revenue beat(8)-1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.53%
Revenue beat(16)9
Avg Revenue beat(16)0.62%
PT rev (1m)5.22%
PT rev (3m)-1.82%
EPS NQ rev (1m)4.26%
EPS NQ rev (3m)3.14%
EPS NY rev (1m)3.58%
EPS NY rev (3m)4.06%
Revenue NQ rev (1m)3.07%
Revenue NQ rev (3m)3.39%
Revenue NY rev (1m)1.87%
Revenue NY rev (3m)1.8%
Valuation
Industry RankSector Rank
PE 20.49
Fwd PE 19.61
P/S 2.36
P/FCF 25.95
P/OCF 18.38
P/B 3.33
P/tB N/A
EV/EBITDA 17.07
EPS(TTM)3.24
EY4.88%
EPS(NY)3.39
Fwd EY5.1%
FCF(TTM)2.56
FCFY3.85%
OCF(TTM)3.61
OCFY5.44%
SpS28.16
BVpS19.91
TBVpS-12.96
PEG (NY)N/A
PEG (5Y)2.96
Profitability
Industry RankSector Rank
ROA 5.22%
ROE 13.97%
ROCE 9.6%
ROIC 6.95%
ROICexc 7.17%
ROICexgc 60.64%
OM 12.62%
PM (TTM) 9.88%
GM 32.74%
FCFM 9.09%
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexcg growth 3Y30.99%
ROICexcg growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 5.9
Debt/EBITDA 3
Cap/Depr 104.44%
Cap/Sales 3.74%
Interest Coverage 250
Cash Conversion 79.15%
Profit Quality 92%
Current Ratio 0.61
Quick Ratio 0.4
Altman-Z 2.52
F-Score5
WACC7.97%
ROIC/WACC0.87
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.86%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-22.11%
EPS Next Y-10.75%
EPS Next 2Y-0.93%
EPS Next 3Y2.37%
EPS Next 5Y4.43%
Revenue 1Y (TTM)0.9%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%0.25%
Revenue Next Year4.78%
Revenue Next 2Y4.5%
Revenue Next 3Y4.26%
Revenue Next 5Y3.62%
EBIT growth 1Y-33.55%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year7.92%
EBIT Next 3Y7.96%
EBIT Next 5Y8.23%
FCF growth 1Y12.76%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y19.95%
OCF growth 3Y5.84%
OCF growth 5Y4.37%